| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Bramwell GJ, Gonye T |
Responses of midbrain neurones to iontophoretically applied 5-hydroxyt... |
Brit.J.Pharmacol. |
1973 |
| Bradley PB, Briggs I |
Further Studies On The Mode Of Action Of Psychotomimetic Drugs: Antago... |
Br. J. Pharmac. |
1974 |
| Gey KF, Georgi H |
Effect Of Neurotropic Agents On Total Pyridoxal, Phosphate And On The ... |
J Neurochem. |
1974 |
| Bradley PB, Griggs I |
Actions of Serotonin and Related Substances on Single Neurons in the B... |
Advanc Biochem Psych... |
1974 |
| Freedman DX |
LSD, Psychotogenic Procedures, and Brain Neurohumors. |
Psychopharmacol Bull |
1975 |
| Bramwell GJ, Goenye T |
Responses of Midbrain Neurones to Micro-Iontophoretically Applied 5-Hy... |
Neuropharmacology |
1976 |
| Briggs I |
Excitatory Responses of Neurones in Rat Bulbar Reticular Formation to ... |
J.Physiol. |
1977 |
| Smythies JR |
On The Molecular Mechanism Of Action Of Hallucinogens |
The Psychopharmacolo... |
1978 |
| Greengard P |
Cyclic nucleotides, phosphorylated proteins and the nervous system |
Federation Proc. |
1979 |
| Mccall RB, Aghajanian GK |
Hallucinogens Potentiate Responses To Serotonin And Norepinephrine In ... |
Life Sciences |
1980 |
| Olney JW, Labruyere J, Pr... |
Pathological changes induced in cerebrocortical neurons by phencyclidi... |
Science |
1989 |
| Ashby CR, Edwards E, Hark... |
Effects of (+/-)-DOI on medial prefrontal cortical cells: a microionto... |
Brain Res |
1989 |
| Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
| Johnson M, Bush LG, Gibb ... |
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... |
Eur J Pharmacol |
1991 |
| Olney JW, Labruyere J, Wa... |
NMDA antagonist neurotoxicity: mechanism and prevention |
Science |
1991 |
| Nash JF, Yamamoto BK |
Methamphetamine neurotoxicity and striatal glutamate release: comparis... |
Brain Res |
1992 |
| White SR, Duffy P, Kaliva... |
Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firi... |
Neuroscience |
1994 |
| Rossner S, Schliebs R, Bi... |
Ibotenic acid lesion of nucleus basalis magnocellularis differentially... |
Brain Res |
1994 |
| Farfel GM, Seiden LS |
Role of hypothermia in the mechanism of protection against serotonergi... |
J Pharmacol Exp Ther |
1995 |
| White SR, Harris GC, Imel... |
Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA... |
Brain Res |
1995 |
| Banerjee PK, Snead OC |
Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric aci... |
J Pharmacol Exp Ther |
1995 |
| Finnegan KT, Taraska T |
Effects of glutamate antagonists on methamphetamine and 3,4-methylened... |
J Neurochem |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Pu C, Broening HW, Vorhee... |
Effect of methamphetamine on glutamate-positive neurons in the adult a... |
Synapse |
1996 |
| Shen M, Piser TM, Seybold... |
Cannabinoid receptor agonists inhibit glutamatergic synaptic transmiss... |
J Neurosci |
1996 |
| Kombian SB, Zidichouski J... |
GABAB receptors presynaptically modulate excitatory synaptic transmiss... |
J Neurophysiol |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Gleitz J, Friese J, Beile... |
Anticonvulsive action of (+/-)-kavain estimated from its properties on... |
Eur J Pharmacol |
1996 |
| Kombian SB, Saleh TM, Fia... |
Ibogaine and a total alkaloidal extract of Voacanga africana modulate ... |
Brain Res Bull |
1997 |
| Colado MI, Granados R, O'... |
Role of hyperthermia in the protective action of clomethiazole against... |
Br J Pharmacol |
1998 |
| Obradovic T, Imel KM, Whi... |
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... |
Brain Res |
1998 |
| Farber NB, Hanslick J, Ki... |
Serotonergic agents that activate 5HT2A receptors prevent NMDA antagon... |
Neuropsychopharmacol... |
1998 |
| Obradovic T, Imel KM, Whi... |
Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucle... |
Brain Res |
1998 |
| Wickelgren I |
Teaching the brain to take drugs |
Science |
1998 |
| Shen M, Thayer SA |
Cannabinoid receptor agonists protect cultured rat hippocampal neurons... |
Mol Pharmacol |
1998 |
| Aghajanian GK, Marek GJ |
Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal ... |
Brain Res |
1999 |
| Berman RM, Cappiello A, A... |
Antidepressant effects of ketamine in depressed patients |
Biol Psychiatry |
2000 |
| West WB, Lou A, Pechersky... |
Antagonism of a PCP drug discrimination by hallucinogens and related d... |
Neuropsychopharmacol... |
2000 |
| Nicotra AS, Parvez H |
Nitric Oxide and Neuronal and Pancreatic Beta Cell Death |
Toxicology |
2000 |
| Fischer HS, Zernig G, Sch... |
MDMA ('ecstasy') enhances basal acetylcholine release in brain slices ... |
Eur J Neurosci |
2000 |
| Schatz DS, Kaufmann WA, S... |
3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein ... |
Synapse |
2000 |
| Mansvelder HD, McGehee DS |
Long-term potentiation of excitatory inputs to brain reward areas by n... |
Neuron |
2000 |
| Braff, DL, Geyer, MA and ... |
Human studies of prepulse inhibition of startle: normal subjects, pati... |
Psychopharmacology |
2001 |
| Vollenweider FX, Geyer MA |
A systems model of altered consciousness: integrating natural and drug... |
Brain Res Bull |
2001 |
| Krupitsky EM, Burakov AM,... |
Attenuation of ketamine effects by nimodipine pretreatment in recoveri... |
Neuropsychopharmacol... |
2001 |
| Mechoulam R, Panikashvili... |
Cannabinoids and brain injury: therapeutic implications |
Trends Mol Med |
2002 |
| Nichols CD, Sanders-Bush ... |
A single dose of lysergic acid diethylamide influences gene expression... |
Neuropsychopharmacol... |
2002 |
| Whitworth TL, Herndon LC,... |
Psychostimulants differentially regulate serotonin transporter express... |
J Neurosci |
2002 |
| van der Stelt M, Veldhuis... |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system |
Mol Neurobiol |
2002 |
| Gandolfi O, Gaggi R, Volt... |
The activation of serotonin receptors prevents glutamate-induced neuro... |
Pharmacol Res |
2002 |
| Umbricht D, Vollenweider ... |
Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Gene... |
Neuropsychopharmacol... |
2002 |
| Weinbroum AA |
Importance of early identification of methylenedioxymethamphetamine ('... |
Eur J Emerg Med |
2003 |
| Croxford JL |
Therapeutic potential of cannabinoids in CNS disease |
CNS Drugs |
2003 |
| Bogen IL, Haug KH, Myhre ... |
Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and v... |
Neurochem Int |
2003 |
| van der Stelt M, Hansen H... |
Biosynthesis of endocannabinoids and their modes of action in neurodeg... |
Neurotox Res |
2003 |
| Stuerenburg HJ, Petersen ... |
Plasma amino acids in ecstasy users |
Neuroendocrinol Lett |
2003 |
| Johnson EA, O\'Callaghan ... |
Brain concentrations of d-MDMA are increased after stress |
Psychopharmacology (... |
2004 |
| Nichols DE |
Hallucinogens |
Pharmacology & Thera... |
2004 |
| Ostroff R, Gonzales M, Sa... |
Antidepressant Effect of Ketamine During ECT |
Am J Psychiatry |
2005 |
| Lambe EK, Aghajanian GK |
Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Co... |
Neuropsychopharmacol... |
2005 |
| Narendran R, Frankle WG, ... |
Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketam... |
Am J Psychiatry |
2005 |
| Ranjan S, Chandra PS |
Modafinil-induced irritability and aggression?: a report of 2 bipolar ... |
J Clin Psychopharmac... |
2005 |
| Wolff K, Winstock AR |
Ketamine : from medicine to misuse |
CNS Drugs |
2006 |
| Zarate CA, Singh JB, Carl... |
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... |
Arch Gen Psychiatry |
2006 |
| Beique JC, Imad M, Mladen... |
Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation... |
Proc Natl Acad Sci U... |
2007 |
| Benneyworth MA, Xiang Z, ... |
A selective positive allosteric modulator of metabotropic glutamate re... |
Mol Pharmacol |
2007 |
| Chipana C, Camarasa J, Pu... |
Memantine prevents MDMA-induced neurotoxicity |
Neurotoxicology |
2008 |
| Deakin JF, Lees J, McKie ... |
Glutamate and the neural basis of the subjective effects of ketamine: ... |
Arch Gen Psychiatry |
2008 |
| Gonzalez-Maeso J, Ang RL... |
Identification of a serotonin/glutamate receptor complex implicated in... |
Nature |
2008 |
| Bossong MG, Niesink RJ |
Adolescent brain maturation, the endogenous cannabinoid system and the... |
Prog Neurobiol |
2010 |
| Vollenweider FX, Kometer ... |
The neurobiology of psychedelic drugs: implications for the treatment ... |
Nat Rev Neurosci |
2010 |
| Sanacora G, Smith MA, Pat... |
Lanicemine: a low-trapping NMDA channel blocker produces sustained ant... |
Mol Psychiatry |
2013 |
| Lally N, Nugent AC, Lucke... |
Anti-anhedonic effect of ketamine and its neural correlates in treatme... |
Transl Psychiatry |
2014 |
| Elston TW, Pandian A, Smi... |
Aniracetam does not alter cognitive and affective behavior in adult C5... |
PLoS One |
2014 |
| Schifano F, Orsolini L, D... |
Novel psychoactive substances of interest for psychiatry |
World Psychiatry |
2015 |
| Battleday RM, Brem AK |
Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived... |
Eur Neuropsychopharm... |
2015 |
| Henderson TA |
Practical application of the neuroregenerative properties of ketamine:... |
Neural Regen Res |
2016 |
| Ingram R, Kang H, Lightma... |
Some distorted thoughts about ketamine as a psychedelic and a novel hy... |
Neuropharmacology |
2018 |
| Bertron JL, Seto M, Linds... |
DARK Classics in Chemical Neuroscience: Phencyclidine (PCP) |
ACS Chem Neurosci |
2018 |
| Zamberlan F, Sanz C, Vivo... |
The varieties of the psychedelic experience: a preliminary study of th... |
Front. Integr. Neuro... |
2018 |
| Botanas CJ, de la Peņa JB... |
Methoxetamine: A foe or friend? |
Neurochem Int |
2019 |
| Bennett R, Yavorsky C, Br... |
Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and P... |
Front Psychiatry |
2022 |